Golden Tate fought the law and the law won. On Tuesday, the NFL denied the Giants wide receiver’s appeal, per a press release.
“This past April, during the off-season, my wife and I decided to see a specialist for fertility
planning,” Tate said in a statement. “I started the treatment prescribed to me and just days later I discovered it contained an ingredient that is on the league’s banned substance list. I immediately discontinued use, I reported the situation to the Independent Administrator of the NFL Policy on Performance-Enhancing Substances, and I spoke with my coaches and general manager. I did all of this well before a failed test was even confirmed.”
Now that the suspension has been upheld, Tate will lose around $1.75M in 2019 money. Perhaps more importantly, the receiver will forfeit his $7.975M in 2020 guarantees. Tate signed a four-year, $37M deal with the Giants this past winter, but he’s already lost at least a chunk of that cash thanks to the suspension.
Following Tate’s suspension and the season-ending injury to Corey Coleman, the Giants’ current WR depth chart is headlined by Sterling Shepard, Cody Latimer, Bennie Fowler, Russell Shepard and Darius Slayton. In positive news, Shepard’s thumb injury is not as serious as once believed and should be ready for the team’s season opener against the Cowboys on Sept. 8.